Key Highlights

  • Adjusted EPS from continuing operations of USD 0.50 beat the consensus estimate of USD 0.48, up from USD 0.17.
  • Net sales of USD 178.7 million rose 7.7% and topped the consensus estimate of USD 175.16 million.
  • Adjusted operating profit climbed 47.9% to USD 13.6 million, and GAAP operating profit was USD 11.5 million versus a loss.
  • Cash reached USD 1.16 billion, and 2026 adjusted EPS guidance of USD 1.60 to USD 1.70 was reaffirmed.

TriMas Corporation (NASDAQ:TRS) reported third quarter 2026 adjusted Diluted Earnings per Share from continuing operations of USD 0.50, above the consensus estimate of USD 0.48, compared with USD 0.17 a year earlier. GAAP diluted EPS from continuing operations was USD 0.37 versus a loss of USD 0.12. Net sales were USD 178.74 million, up 7.7% from USD 166.02 million and above the consensus estimate of USD 175.16 million, with organic growth of 7.2% and a 0.5% currency benefit. The company said the EPS gain reflected interest income on its cash, cost reductions and a lower share count.

Segment Results and Profit Drivers

TriMas Packaging net sales rose 8.8% to USD 147.6 million on growth across beauty and personal care, food and beverage, life sciences and industrial end markets, and its adjusted operating profit increased to USD 20.4 million from USD 18.2 million. Specialty Products sales rose 2.7% to USD 31.2 million, but operating profit fell to USD 0.1 million from USD 2.4 million as raw material cost recovery lagged and machine downtime and labor ramp up caused inefficiencies.

Other income, net was USD 9.9 million compared with USD 1.1 million, reflecting interest earned on cash. Selling, general and administrative expense fell to USD 24.8 million from USD 29.6 million, and the prior year quarter included USD 8.0 million of asbestos related costs. Net Income including discontinued operations was USD 19.4 million.

2026 Outlook and Commentary

President and Chief Executive Officer Thomas Snyder said the third quarter had not yet fully reflected the benefits of recent actions and was affected by temporary throughput challenges at Norris Cylinder. The company reaffirmed adjusted diluted EPS guidance of USD 1.60 to USD 1.70, with GAAP diluted EPS of USD 1.06 to USD 1.13, and assumes about USD 10 million of fourth quarter interest income.

Sales growth across Packaging and Specialty Products is now guided to 4% to 6%, up from 3% to 6%, with about 250 basis points of adjusted Operating Margin expansion. The outlook includes announced acquisitions and divestitures as of October 29 and assumes no significant impact from global conflicts on input costs or demand.

Capital Deployment and Dates to Follow

An agreement to sell Rapak, a flexible bag-in-box provider, was signed in October, and the transaction is scheduled to close in November 2026. The Aerospace sale closed March 16, 2026 for about USD 1.5 billion in cash, producing roughly USD 1.2 billion of net after-tax proceeds, and the remaining balance is invested in interest bearing accounts pending redeployment.

Cash stood at USD 1,158.5 million against total Debt of USD 397.1 million, a net cash position of USD 761.4 million, and net Leverage was 1.7x under the Credit agreement. The company repurchased 233,150 shares for USD 9.3 million in the quarter, with USD 67.3 million left under authorization, and paid a quarterly Dividend of USD 0.04. Free Cash Flow adjusted for special items was USD 20.9 million, while reported Operating Cash Flow was negative USD 66.7 million.